- Home
- TMDX vs HAFN Comparison
TMDX vs HAFN Comparison
Compare TMDX & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- HAFN
- Stock Information
- Founded
- TMDX 1998
- HAFN 2012
- Country
- TMDX United States
- HAFN Singapore
- Employees
- TMDX N/A
- HAFN N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HAFN
- Sector
- TMDX Health Care
- HAFN
- Exchange
- TMDX Nasdaq
- HAFN Nasdaq
- Market Cap
- TMDX 2.3B
- HAFN 2.7B
- IPO Year
- TMDX 2019
- HAFN N/A
- Fundamental
- Price
- TMDX $127.12
- HAFN $5.06
- Analyst Decision
- TMDX Buy
- HAFN Strong Buy
- Analyst Count
- TMDX 10
- HAFN 1
- Target Price
- TMDX $122.89
- HAFN $6.50
- AVG Volume (30 Days)
- TMDX 1.1M
- HAFN 1.6M
- Earning Date
- TMDX 05-08-2025
- HAFN 05-15-2025
- Dividend Yield
- TMDX N/A
- HAFN 18.08%
- EPS Growth
- TMDX N/A
- HAFN N/A
- EPS
- TMDX 1.41
- HAFN 1.20
- Revenue
- TMDX $488,227,000.00
- HAFN $2,631,664,000.00
- Revenue This Year
- TMDX $32.58
- HAFN N/A
- Revenue Next Year
- TMDX $21.65
- HAFN $1.88
- P/E Ratio
- TMDX $90.86
- HAFN $4.20
- Revenue Growth
- TMDX 64.43
- HAFN N/A
- 52 Week Low
- TMDX $55.00
- HAFN $3.61
- 52 Week High
- TMDX $177.37
- HAFN $8.99
- Technical
- Relative Strength Index (RSI)
- TMDX 76.52
- HAFN N/A
- Support Level
- TMDX $118.79
- HAFN N/A
- Resistance Level
- TMDX $130.48
- HAFN N/A
- Average True Range (ATR)
- TMDX 4.49
- HAFN 0.00
- MACD
- TMDX -0.15
- HAFN 0.00
- Stochastic Oscillator
- TMDX 83.53
- HAFN 0.00
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.